BioAge Appoints Rekha Hemrajani and Jason Coloma to its Board of Directors

BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target the molecular causes of aging to extend healthy human lifespan, today announced the appointment of Rekha Hemrajani and Jason Coloma to the companys board of directors.